Zalicus
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.
Launch date
Employees
Market cap
-
Enterprise valuation
€31—46m (Dealroom.co estimates Jun 2011.)
Cambridge Massachusetts (HQ)
Authorizing premium user...